C4 THERAPEUTICS INC (CCCC:NASDAQ)
$2.89 0.13 (4.7101%)
Analysed C4 THERAPEUTICS INC (CCCC:NASDAQ) News Sources
BRAF Mutated Non-small Cell Lung Cancer (NSCLC) Market Insight, Epidemiology, and Market Forecast Report 2022-2026 & 2026-2036 Featuring Novartis, Genentech, Fore Biotherapeutic, and C4 Therapeutics
13-04-2026
yahoo.com
Roche Explores Degrader Antibody Conjugates To Support Oncology Pipeline
12-04-2026
yahoo.com
Roche and C4 Therapeutics to advance degrader-antibody conjugates research
10-04-2026
pharmaceutical-technology.com
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
09-04-2026
yahoo.com
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?
27-03-2026
yahoo.com
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma
25-03-2026
yahoo.com
Analysts See Significant Upside in C4 Therapeutics (CCCC) Stock
24-03-2026
yahoo.com
C4 Therapeutics Details MOMENTUM Phase 2 Start, Eyes Near-Term Decision on EGFR Program at Barclays Confab
14-03-2026
marketbeat.com
C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data
10-03-2026
yahoo.com
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09-03-2026
yahoo.com
What is the current price of C4 THERAPEUTICS INC (CCCC:NASDAQ)?
The current price of C4 THERAPEUTICS INC (CCCC:NASDAQ) is $2.89.
C4 THERAPEUTICS INC (CCCC:NASDAQ) absolute price change since previous trading day?
The absolute price change of C4 THERAPEUTICS INC (CCCC:NASDAQ) since the previous trading day is $0.13.
C4 THERAPEUTICS INC (CCCC:NASDAQ) percentage price change since previous trading day?
The percentage price change of C4 THERAPEUTICS INC (CCCC:NASDAQ) since the previous trading day is 4.7101%.
What is the most recent average sentiment score for C4 THERAPEUTICS INC (CCCC:NASDAQ)?
The most recent average sentiment score for C4 THERAPEUTICS INC (CCCC:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for C4 THERAPEUTICS INC (CCCC:NASDAQ)?
The most recent sentiment for C4 THERAPEUTICS INC (CCCC:NASDAQ) is .
SEC-8K** Filing Available For C4 THERAPEUTICS INC (CCCC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.